Release Date
Michael R. Grunwald, MD, FACP - The A-Factor in Myelofibrosis: Addressing Anemia and Prioritizing Personalized Team Management
Michael R. Grunwald, MD, FACP - The A-Factor in Myelofibrosis: Addressing Anemia and Prioritizing Personalized Team Management
Associate Professor Jim Whittle, MBBS, PhD, FRACP / Katie Metrock, MD - Moving MEK Inhibitor Therapy FORWARD in NF1: A Neuro-Oncology FOrum on Real-World Application of Recent Data for Improving Patient Care
Dr. Paula Cramer - Mapping the Pathways to Long-Term Treatment Benefit in Chronic Lymphocytic Leukemia (CLL): Strategies for Aligning Patient Priorities With Evidence for Initiating and Sequencing Targeted Therapy
Michael Heinrich, MD - Redefining Interprofessional Care Paradigms in Gastrointestinal Stromal Tumors (GIST): Clinical "Take-Homes" for Established and Rapidly Emerging Evidence on TKIs Across the Disease Continuum
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD - Rethinking the CLL Treatment Sequence: Guidance on Selecting and Sequencing Modern Treatment for Sustained Efficacy Across Lines of Therapy